DONALD YEE to Treatment Outcome
This is a "connection" page, showing publications DONALD YEE has written about Treatment Outcome.
Connection Strength
0.068
-
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia. N Engl J Med. 2026 Apr 09; 394(14):1388-1398.
Score: 0.020
-
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 study. Blood Adv. 2025 May 27; 9(10):2461-2472.
Score: 0.019
-
Safety and efficacy of a glycoPEGylated rFVIII (turoctocog alpha pegol, N8-GP) in paediatric patients with severe haemophilia A. Thromb Haemost. 2017 08 30; 117(9):1705-1713.
Score: 0.011
-
Assessment of an Electronic Intervention in Young Women with Heavy Menstrual Bleeding. J Pediatr Adolesc Gynecol. 2017 Apr; 30(2):243-246.
Score: 0.010
-
Catheter-directed thrombolysis for severe pulmonary embolism in pediatric patients. Ann Vasc Surg. 2014 Oct; 28(7):1794.e1-7.
Score: 0.009